Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C B Johnson

Showing results (191-200 of 203) with videos related to

Pageof 21
Sort By:
NPJ Dementia|November 6, 2025
Voiceprints of cognitive impairment: analyzing digital voice for early detection of Alzheimer's and related dementiasNeguine Rezaii, Bonnie Wong, Paul Aisen, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 6, 2026
Criterion and convergent validity of plasma biomarkers in early-onset Alzheimer's disease: Initial findings from LEADSDustin B Hammers, Angelina Polsinelli, Ani Eloyan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 19, 2025
Dissociable spatial topography of cortical atrophy in early-onset and late-onset Alzheimer's disease: A head-to-head comparison of the LEADS and ADNI cohortsYuta Katsumi, Alexandra Touroutoglou, Michael Brickhouse, et al.
Nature Medicine|July 15, 2025
The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and agingFarhad Imam, Rowan Saloner, Jacob W Vogel, et al.
Brain Communications|June 8, 2026
Tau topography subtypes account for clinical heterogeneity and longitudinal trajectories in early-onset Alzheimer's diseaseMarlene Lin, Konstantinos Chiotis, Piyush Maiti, et al.
Molecular Neurodegeneration|January 6, 2026
OMG! A proteomic determinant of neurodegenerative resiliencyMichael R Duggan, Hamilton Se-Hwee Oh, Philipp Frank, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 15, 2025
Tablet-based Cognitive Assessment Tool (TabCAT) in a multisite study of early-onset Alzheimer's diseaseWepnyu Yembe Njamnshi, Konstantinos Chiotis, Elena Tsoy, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Distinct Tau PET Dynamics in Early vs. Late Age-of-Onset Alzheimer's diseaseKonstantinos Chiotis, Ganna Blazhenets, David N Soleimani-Meigooni, et al.
Annals of Neurology|March 17, 2025
Amyloid PET in Sporadic Early- Versus Late-Onset Alzheimer's Disease: Comparison of the LEADS and ADNI CohortsJulien Lagarde, Piyush Maiti, Daniel R Schonhaut, et al.
Research Square|April 8, 2024
Large-scale network analysis of the cerebrospinal fluid proteome identifies molecular signatures of frontotemporal lobar degenerationRowan Saloner, Adam Staffaroni, Eric Dammer, et al.
Pageof 21

Showing results (191-200 of 203) with videos related to

Sort By:
Pageof 21
NPJ Dementia|November 6, 2025
Voiceprints of cognitive impairment: analyzing digital voice for early detection of Alzheimer's and related dementiasNeguine Rezaii, Bonnie Wong, Paul Aisen, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|May 6, 2026
Criterion and convergent validity of plasma biomarkers in early-onset Alzheimer's disease: Initial findings from LEADSDustin B Hammers, Angelina Polsinelli, Ani Eloyan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 19, 2025
Dissociable spatial topography of cortical atrophy in early-onset and late-onset Alzheimer's disease: A head-to-head comparison of the LEADS and ADNI cohortsYuta Katsumi, Alexandra Touroutoglou, Michael Brickhouse, et al.
Nature Medicine|July 15, 2025
The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and agingFarhad Imam, Rowan Saloner, Jacob W Vogel, et al.
Brain Communications|June 8, 2026
Tau topography subtypes account for clinical heterogeneity and longitudinal trajectories in early-onset Alzheimer's diseaseMarlene Lin, Konstantinos Chiotis, Piyush Maiti, et al.
Molecular Neurodegeneration|January 6, 2026
OMG! A proteomic determinant of neurodegenerative resiliencyMichael R Duggan, Hamilton Se-Hwee Oh, Philipp Frank, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 15, 2025
Tablet-based Cognitive Assessment Tool (TabCAT) in a multisite study of early-onset Alzheimer's diseaseWepnyu Yembe Njamnshi, Konstantinos Chiotis, Elena Tsoy, et al.
Medrxiv : the Preprint Server for Health Sciences|February 6, 2026
Distinct Tau PET Dynamics in Early vs. Late Age-of-Onset Alzheimer's diseaseKonstantinos Chiotis, Ganna Blazhenets, David N Soleimani-Meigooni, et al.
Annals of Neurology|March 17, 2025
Amyloid PET in Sporadic Early- Versus Late-Onset Alzheimer's Disease: Comparison of the LEADS and ADNI CohortsJulien Lagarde, Piyush Maiti, Daniel R Schonhaut, et al.
Research Square|April 8, 2024
Large-scale network analysis of the cerebrospinal fluid proteome identifies molecular signatures of frontotemporal lobar degenerationRowan Saloner, Adam Staffaroni, Eric Dammer, et al.
Pageof 21